Emergent BioSolutions | EBS - BORÇ





BORÇ Değişiklik Tarih
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 1.58B 1.51B 2026-03
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 607.23M 3.26M 2026-09
BioMarin Pharmaceutical USD 4.2B 2.76B 2026-06
Coherus Biosciences USD 294.92M 1.25M 2025-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Exelixis USD 162.2M 3.73M 2026-09
Glaxosmithkline GBP 23.7B 4.65B 2026-09
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Lonza CHF 4.71B 915M 2024-12
Merck USD 53.91B 4.79B 2026-06
Moderna USD 1.29B 11M 2026-06
Myriad Genetics USD 59.3M 19.7M 2025-03
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 401.8M 4.4M 2026-06
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 63.19B 536M 2026-06
PTC Therapeutics USD 2.84B 2.15B 2026-09
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12